US 7304061
Heterocyclic inhibitors of ERK2 and uses thereof
granted A61PA61P35/00
Quick answer
US patent 7304061 (Heterocyclic inhibitors of ERK2 and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P35/00